Loading…
HYPD
Hyperion Defi Inc
NASDAQ· Healthcare· Biotechnology· CUSIP 30234E203
$3.92-3.09%Price as of Sep 28, 20:02 UTC · updated once a day, after the close
Key metrics
- Market cap
- $60.84M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.6x
- Dividend yield
- —
- Payout
- —
- EPS
- -$3.86
- ROE
- 9.55%
- Profit margin
- 474.87%
- Revenue growth
- —
- Beta
- 2.53
- 52-week high
- $11.89
- 52-week low
- $2.34
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -98.7% over 5Y.
today you would have $10.31▼ -99.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $3.56 | $11.68 | $166.40 | $130.40 | $320.00 | $484.80 | $358.40 | $228.00 | |
| P/S | 77.6x | 49.9x | 576.6x | 27988.5x | — | 9.1x | 77.6x | — | — |
| P/B | 6.2x | 1.0x | — | 11.8x | 3.6x |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| IMAImageneBio, Inc. | $5.34 | — | 0.4x | — | -82.68% | $60.74M |
| TLPHTalphera Inc | $1.20 | — | 3.3x | — | -143.36% | $62.29M |
| SERSerina Therapeutics, Inc. | $2.46 | — | 3.3x | — | -207.94% | $62.49M |
| XLOXilio Therapeutics, Inc. | $9.00 |
About the company
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
- 9
- Dallas, United States
Company description provided by Yahoo Finance.